ZALTRAP, in combination with 5-fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of ZALTRAP (ziv-aflibercept) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ZALTRAP (ziv-aflibercept) medicine cost price in India.
The order for ZALTRAP (ziv-aflibercept) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
What Ziv-aflibercept Is Used For: Treatment of patients with metastatic colorectal cancer. Ziv-aflibercept is used in combination with other chemotherapy agents.
ZALTRAP® (ziv-aflibercept) for Intravenous Infusion. Approval: August 2012
Generic Name: ziv-aflibercept
Single-use vials: 100 mg/4 mL (25 mg/mL), 200 mg/8 mL (25 mg/mL)
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ZALTRAP (ziv-aflibercept) on prescription and Import License in Patient's Name only.
For overseas patients, ZALTRAP (ziv-aflibercept) can be made available in Send your enquiry to find ZALTRAP (ziv-aflibercept) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For ZALTRAP (ziv-aflibercept) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Ziv-aflibercept correlated with BCVA, CMT improvements For More Details
Ziv-aflibercept may be safe, less expensive alternative to other anti-VEGF treatmentsReadMore